Reports for ACTAVIS PHARMA COMPANY
Company Name
ACTAVIS PHARMA COMPANY
Totals |
||
Shortage reports |
13 |
|
| Actual shortage: | 7 (54%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 6 (46%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 56 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
58 (84%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT RAMIPRIL | 5MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65139 |
| ACT LOSARTAN | 25MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65136 |
| ACT LOSARTAN | 25MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65133 |
| ACT LOSARTAN | 100MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65130 |
| ACT LISINOPRIL | Discontinued | 2018-10-22 | 2018-10-22 | 65127 | ||
| ACT LISINOPRIL | Discontinued | 2018-10-22 | 2018-10-22 | 65124 | ||
| ACT LISINOPRIL | Discontinued | 2018-10-22 | 2018-10-22 | 65121 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT PAROXETINE | 10MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65061 |
| ACT PAROXETINE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65057 |
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT GEMCITABINE | 38MG | SOLUTION | Discontinued | 2018-10-12 | 2018-10-12 | 63998 |
| ACT RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63995 |